AF (122) | n-AF (372) | p value | |
Mean (95%CI) | Mean (95%CI) | ||
Age | 65.5 (62 - 68.8) | 60 (58 - 61.8) | 0.041 |
Males | 72 (59%) | 266 (71.5%) | 0.013 |
Females | 50 (41%) | 106 (28.5%) | |
Length of hospitalization | 5.2 (4.1 - 6.4) | 4.5 (3.9 - 4.1) | 0.006 |
BMI | 28.5 (26.1 - 30.8) | 29.1 (28.1 - 30.1) | 0.921 |
HTN | 99 (81%) | 294 (79%) | 0.698 |
DM | 36 (29.5%) | 105 (28.2%) | 0.818 |
Metabolic syndrome | 18 (14.8%) | 48 (12.9%) | 0.646 |
Dyslipidemia | 82 (67.2%) | 255 (68.5%) | 0.823 |
Known IHD | 36 (29.5%) | 131 (35.2%) | 0.271 |
Previous PCI | 7 (5.7%) | 52 (14%) | 0.015 |
Previous CABG/valve | 7 (5.7%) | 27 (7.3%) | 0.827 |
Previous vascular surgery | 1 (0.8%) | 8 (2.2%) | 0.516 |
Family history CAD | 1 (0.8%) | 3 (0.8%) | 1.000 |
HOCM | 1 (0.3%) | 1 (0.8%) | 0.433 |
Valvular heart disease | 32 (26.2%) | 52 (14%) | 0.003 |
Other congenital heart disease | 2 (1.6%) | 7 (1.9%) | 1.000 |
CHF | 47 (38.5%) | 64 (17.2%) | 0.001 |
Rheumatic heart disease | 11 (9%) | 7 (1.9%) | 0.001 |
Old PTMCA | 6 (4.9%) | 1 (0.3%) | 0.001 |
CVA | 3 (2.5%) | 9 (2.4%) | 1.000 |
Chronic renal | 11 (9%) | 24 (6.5%) | 0.318 |
Failure | |||
Anemia | 10 (8.2%) | 25 (6.7%) | 0.548 |
COPD | 19 (15.6%) | 83 (22.3%) | 0.546 |
Current or previous smoker | 37 (30.3%) | 147 (39.6%) | 0.013 |
Cancer | 3 (2.5%) | 14 (3.8%) | 0.775 |
Other co-morbidities | 14 (11.5%) | 44 (11.8%) | 1.000 |
Echo performed | 118 (96.7%) | 364 (97.8%) | 0.502 |
Stress testing/CT angio | 6 (4.7%) | 35 (9.1%) | 0.093 |
LV Ejection Fraction | 49.5 (43.1 - 55.8) | 52.1 (49.5 - 54.6) | 0.660 |
Moderate/severe diastolic dysfunction | 26 (21.3%) | 54 (14.5%) | 0.287 |
Moderate/severe valvular abnormality | 43 (35.2%) | 62 (16.7%) | 0.001 |
Wall motion abnormality | 23 (18.9%) | 144 (38.7%) | 0.001 |